- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05159648
A Study to Evaluate ICU Simulation Experience in the Cardiothoracic Surgical Population to Reduce Post-operative Delirium
March 24, 2025 updated by: Robert (Bobby) J. Anderson, Mayo Clinic
Pre-operative, Multi-sensory ICU Simulation Experience to Reduce Post-operative Delirium in the Cardiothoracic Surgical Population
The purpose of this study is to evaluate the effect of a pre-ICU admission virtual reality ICU simulation on post-operative delirium in the elective cardiothoracic surgical population while in the intensive care unit.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
234
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with normal neurologic function scheduled for elective cardiothoracic surgery.
Description
Inclusion Criteria:
- Baseline normal neurological function pre-operatively.
- Planned use of mechanical ventilator with endotracheal tube post-operatively after planned cardiothoracic surgical procedure.
Exclusion Criteria:
- Chronic dementia, Alzheimer's disease, or other chronic neurological disease (i.e., Bi-Polar).
- Chronic use of neurological altering medications such as benzodiazepines, psychotropic, anti-depressants, anxiolytics.
- Patient undergoing emergent surgery.
- Use of post-operative cardiopulmonary support devices such as ECMO (extracorporeal membrane oxygenation), intra-aortic balloon pump, total artificial heart, or other similar device.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Confusion Assessment Method for the ICU (CAM-ICU)
Time Frame: Once, during ICU admission within 24 hours of ICU admission.
|
Number of Participants with one or more Positive Confusion Assessment.
"Confusion Assessment Method for the ICU" - Establishes ability to detect delirium in high-risk settings such as the intensive care unit.
Recorded during every scheduled patient assessment by nurse and with mental changes.
Reports as "Positive" or "Negative" with response to different assessments regarding level of consciousness, acute onset or fluctuating course of mental status and inattention.
|
Once, during ICU admission within 24 hours of ICU admission.
|
|
Subjective Experiential Outcome After ICU Simulation
Time Frame: Once, immediately following the virtual reality ICU simulation session.
|
Survey questions to understand patient's subjective experience during the virtual reality ICU simulation session.
Internally created survey.
The number of subjects who completed the survey.
|
Once, immediately following the virtual reality ICU simulation session.
|
|
Subjective Experiential Outcome After ICU Admission
Time Frame: Once, up to 3 days after transfer out of the Intensive Care Unit.
|
Survey questions to understand patient's subjective experience in the intensive care unit.
The number of subjects who completed the survey.
|
Once, up to 3 days after transfer out of the Intensive Care Unit.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of ICU Admission
Time Frame: During ICU admission; average 2 days
|
Number of hours in the intensive care unit measured in the electronic health record from admission time to the ICU to discharge time from the ICU.
|
During ICU admission; average 2 days
|
|
Duration of Intravenous Sedation in the ICU
Time Frame: During ICU admission; average 2 days
|
Number of hours of intravenous sedation in the ICU measured through the medication administration record via the electronic healthcare record.
|
During ICU admission; average 2 days
|
|
Duration of Mechanical Ventilation in the ICU
Time Frame: During ICU admission; average 2 days
|
Number of hours of mechanical ventilation in the ICU measured via the electronic healthcare record with data imported into the electronic healthcare record directly from the mechanical ventilator.
|
During ICU admission; average 2 days
|
|
Use of Anti-psychotic Medications
Time Frame: Throughout ICU admission; average of 5 days
|
Number of antipsychotic medication administrations in the ICU measured through the medication administration record via the electronic healthcare record.
|
Throughout ICU admission; average of 5 days
|
|
Cardiopulmonary Bypass
Time Frame: During OR case; average 12 hours
|
Number of hours of use of cardiopulmonary bypass in the operating room via record from the cardiopulmonary bypass perfusionist in the operating room imported into the electronic healthcare record.
|
During OR case; average 12 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Robert Anderson, APRN, CNP, DNP, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 2, 2021
Primary Completion (Actual)
June 1, 2022
Study Completion (Actual)
August 20, 2023
Study Registration Dates
First Submitted
October 13, 2021
First Submitted That Met QC Criteria
December 10, 2021
First Posted (Actual)
December 16, 2021
Study Record Updates
Last Update Posted (Actual)
April 8, 2025
Last Update Submitted That Met QC Criteria
March 24, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-008071
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-Operative Delirium
-
McGill University Health Centre/Research Institute...Sunnybrook Health Sciences Centre; University of British Columbia; University... and other collaboratorsRecruitingPost Operative Pain | Post-Op Complication | Post-cardiac Surgery | Post Operative DeliriumCanada
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedPost Operative Pain | Post Operative DeliriumTurkey
-
Tanta UniversityCompletedPost Operative DeliriumEgypt
-
Amira Hassan Ahmed AliNot yet recruitingPost Operative DeliriumEgypt
-
Imperial College Healthcare NHS TrustRecruitingCardiac Surgery | Intensive Care Unit Delirium | Post Operative DeliriumUnited Kingdom
-
Beni-Suef UniversityCompletedPostoperative Cognitive Dysfunction | Post Operative DeliriumEgypt
-
Oregon Health and Science UniversityRecruitingNeurocognitive Disorders | Anesthesia | Post-operative Cognitive Dysfunction | Post-operative DeliriumUnited States
-
Wenzhou Medical UniversityNational Research Institute for Family Planning, ChinaCompletedPost Operative DeliriumChina
-
Charite University, Berlin, GermanyCompletedPost-operative Cognitive Dysfunction | Post-operative DeliriumGermany
-
Albert Einstein College of MedicineNational Institute on Aging (NIA)CompletedPost-operative Delirium | Post-operative Cognitive DeclineUnited States